“If mutual funds didn’t exist today, would they have to be invented?” asks manager John Neff of the Akre Focus mutual fund. “I think the answer is very uncomfortably ‘no.’” ...

Two cancer experts go head to head, arguing the case for and against a targeted prostate cancer screening programme.

Learn more about prostate cancer and why there is a debate over whether or not patients should get tested for it.

By targeting a newly uncovered weakness in prostate cancer cells, this could offer an improved treatment for the disease.

Midlife hits fast, and your body gets more opinionated about everything with age. However, that is not a crisis; it is a cue ...